Pityriasis rosea
☆ Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
Pityriasis rosea amin'ny lamosina ― Macules sy tasy tsy misy soritr'aretina, tsy toy ny fiposahan'ny rongony izay mangidihidy matetika.
raha mangidihidy be ilay izy dia mety miahiahy ny aretina allergie toy ny nummular eczema.
References
Pityriasis rosea dia toetry ny hoditra vonjimaika voamarika amin'ny fisondrotry ny tasy sy ny kirany. Matetika izy io dia manomboka amin'ny paty tokana, fantatra amin'ny anarana hoe herald patch , arahin'ny paty bebe kokoa miseho mandritra ny tapa-bolana manaraka. Na izany aza, tsy ny olona rehetra voan'ny pityriasis rosea no manana an'io patch voalohany io. Matetika ireo paty ireo dia mamorona lamina miavaka mitovy amin'ny hazo krismasy eo amin'ny vatan-kazo sy ny rantsana ambony.
Pityriasis rosea, also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus is an acute self-limiting papulosquamous disorder. It is often characterized by an initial herald patch, followed by scaly oval patches within 2 weeks. However, the herald patch is not always present. The scaly oval patches typically distribute in a Christmas-tree pattern on the trunk and proximal extremities. This activity reviews the evaluation and treatment of pityriasis rosea and the importance of the interprofessional team in recognizing and managing patients with this condition.
Pityriasis rosea, also known as pityriasis circinata, roseola annulata, and herpes tonsurans maculosus is an acute self-limiting papulosquamous disorder. It is often characterized by an initial herald patch, followed by scaly oval patches within 2 weeks. However, the herald patch is not always present. The scaly oval patches typically distribute in a Christmas-tree pattern on the trunk and proximal extremities. This activity reviews the evaluation and treatment of pityriasis rosea and the importance of the interprofessional team in recognizing and managing patients with this condition.
Pityriasis rosea dia maimaika mahazatra izay matetika manomboka amin'ny tapa-kazo iray eo amin'ny vatan-kazo ary miparitaka mandrakotra ny vatan-kazo sy ny rantsantanana. Ny diagnostika dia miankina amin'ny fizahana klinika. Ny paty voalohany dia mipoitra mena miaraka amin'ny sisin-tany mitsangana sy afovoany. Mipoitra amin'ny ankapobeny ny maimaika rehefa afaka roa herinandro. Ny marary dia mety ho reraka, maloiloy, aretin'andoha, fanaintainan'ny tonon-taolana, fivontosan'ny lymph node, tazo, ary aretin'ny tenda miaraka amin'ny maimaika. Ny toe-javatra mitovy amin'izany dia ny syphilis, seborrheic dermatitis, eczema, ary ny hafa. Ny fitsaboana dia mikendry ny hanamaivanana ny soritr'aretina miaraka amin'ny corticosteroids na antihistamines. Acyclovir dia mety hanampy amin'ny toe-javatra sasany. Ny tranga henjana dia mety hahazo tombony amin'ny phototherapy UV. Ny aretina mandritra ny fitondrana vohoka indraindray dia mifandray amin'ny afa-jaza.
Pityriasis rosea is a common rash that usually begins with a single patch on the trunk and spreads to cover the trunk and limbs. Diagnosis relies on clinical examination. The initial patch appears red with a raised border and sunken center. The rash typically emerges about two weeks later. Patients may experience fatigue, nausea, headaches, joint pain, swollen lymph nodes, fever, and sore throat alongside the rash. Similar conditions include syphilis, seborrheic dermatitis, eczema, and others. Treatment aims to alleviate symptoms with corticosteroids or antihistamines. Acyclovir may help in some cases. Severe instances may benefit from UV phototherapy. The disease during pregnancy sometimes has been linked to miscarriage.
Pityriasis rosea is a common rash that usually begins with a single patch on the trunk and spreads to cover the trunk and limbs. Diagnosis relies on clinical examination. The initial patch appears red with a raised border and sunken center. The rash typically emerges about two weeks later. Patients may experience fatigue, nausea, headaches, joint pain, swollen lymph nodes, fever, and sore throat alongside the rash. Similar conditions include syphilis, seborrheic dermatitis, eczema, and others. Treatment aims to alleviate symptoms with corticosteroids or antihistamines. Acyclovir may help in some cases. Severe instances may benefit from UV phototherapy. The disease during pregnancy sometimes has been linked to miscarriage.
In most cases, PR does not influence pregnancy or birth outcomes. Analysis of pooled data from our study and from previous studies revealed that the week of pregnancy at onset of PR was inversely associated with an unfavorable outcome (odds ratio [OR] = 0.937; 95 % CI 0.883 to 0.993). In addition, duration of PR (OR = 1.432; 95 % CI 1.129 to 1.827), additional extracutaneous symptoms (OR = 4.112; 95 % CI 1.580 to 10.23), and widespread rash distribution (OR 5.203, 95 % CI 1.702 to 14.89) were directly associated with unfavorable outcome.
Pityriasis rosea dia aretina hoditra mahazatra izay mamely ny tanora sy ny tanora lehibe (10-35 taona) , mihoatra ny vehivavy. Manomboka tampoka izany, matetika miaraka amin'ny paty iray fantatra amin'ny anarana hoe Herald patch eo amin'ny vatan-kazo, arahin'ny fivontosana misy pentina boribory mavokely mavokely voahodidina peratra volondavenona. Matetika ireo pentina ireo dia mamorona lamina mitovy amin'ny Christmas tree eo amin'ny vatan-kazo. Matetika maharitra 6 ka hatramin'ny 8 herinandro ny maimaika. Pityriasis rosea dia misy fiantraikany eo amin'ny 0,68% amin'ny olona manatona mpitsabo aretin-tsaina, saingy mety miovaova amin'ny 0,39% hatramin'ny 4,8% izany.
Pityriasis rosea (PR) is a relatively common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years), slightly more common in females. It has a sudden onset, and in its typical presentation, the eruption is preceeded by a solitary patch termed “herald patch”, mainly located on the trunk. Few days later, a secondary eruption appears, with little pink, oval macules, with a grayish peripheral scaling collarette around them. The secondary lesions adopt a characteristic distribution along the cleavage lines of the trunk, with a configuration of a “Christmas tree”. In most cases, the eruption lasts for 6 to 8 wk. Its incidence has been estimated to be 0.68% of dermatologic patients, varying from 0.39% to 4.8%.
Pityriasis rosea (PR) is a relatively common, self-limited papulo-squamous dermatosis of unknown origin, which mainly appears in adolescents and young adults (10-35 years), slightly more common in females. It has a sudden onset, and in its typical presentation, the eruption is preceeded by a solitary patch termed “herald patch”, mainly located on the trunk. Few days later, a secondary eruption appears, with little pink, oval macules, with a grayish peripheral scaling collarette around them. The secondary lesions adopt a characteristic distribution along the cleavage lines of the trunk, with a configuration of a “Christmas tree”. In most cases, the eruption lasts for 6 to 8 wk. Its incidence has been estimated to be 0.68% of dermatologic patients, varying from 0.39% to 4.8%.
Na dia tsy mazava tsara aza ny antony, dia inoana fa misy ifandraisany amin'ny herpesvirus olombelona 6 na herpesvirus olombelona 7. Toa tsy mifindra izy io. Ny fanafody sasany dia mety miteraka maimaika mitovy amin'izany. Ny aretina dia mifototra amin'ny soritr'aretina ary matetika tsy ilaina ny biopsy.
Amin'ny maha aretina mahazatra azy, manodidina ny 1,3% amin'ny olona no voan'ny aretina amin'ny fotoana iray. Matetika izy io no mitranga amin'ny olona eo anelanelan'ny 10 sy 35 taona.
○ Diagnose sy Fitsaboana
Raha maharitra mihoatra ny 1 volana izany, dia mety ilaina ny fanadihadiana amin'ny antsipiriany mba hanavahana azy amin'ny aretina hafa (parapsoriasis, syphilis).
#Phototherapy
#OTC steroid ointment